Blog

Reaching Diverse Patient Populations to Drive Inclusivity in Trials

The COVID-19 pandemic was catalytic in highlighting gaps in health outcomes across the globe, with global health inequity disproportionately impacting minorities and communities of color.With a litany of factors influencing individual patient outcomes and access to healthcare...
Blog

Intellectual Property (IP) Strategies to Consider for Life Sciences Start-Ups

Intellectual property (IP) is one of the most valuable assets a life sciences innovator or start-up has. While these companies are often built on the foundations of successful pre-clinical studies, they face a substantial amount of time between obtaining regulatory approvals...
Blog

Connecting with Diverse Patients: How Call Centers Can Improve Patient Recruitment and Retention

Do you recruit patients for clinical trials? If the answer is yes, then how do you reach potential participants? Through emails? Ads on the radio? Do you call someone and see if they are interested?There are many different ways patients are recruited for clinical trials: in...
Blog

Electronic Product Information – Everything You Need to Know

One of the latest initiatives being spearheaded by EMA is publishing ePI, or electronic product information. In some respects, the pharma industry has lagged behind other major industries in terms of how documentation and critical information is relayed to the end patient....
Blog

3 Benefits of Centralizing Global Content for eCOA Migration

In recent years, life sciences organizations have been looking for a standardized approach to collecting global patient data while maintaining compliance and adhering to study timeline milestones. For clinical trials launched across multiple regions, time zones, and patient...
Blog

Pharma Digital Marketing: Trends for Customer Engagement

Trends for Pharma Digital MarketingAll you need to know about above-the-line and below-the-line advertising and multichannel and omnichannel engagementIn today’s evolving digital landscape, companies are looking for the best ways to improve customer experience and...
Blog

Why Automate the Literature Monitoring Process?

A key concern for pharma companies is keeping a close eye on publications that might mention their product and its potential impact on the public. These publications can be extremely dense in volume, commanding careful review of multiple documents across several different...
Blog

Driving Patient Engagement in Medicine Development and Decision-Making – Challenges and Opportunities

The need for integrating patient engagement strategies early in the medicine development process has sparked widespread discussion in the pharmaceutical industry and beyond. This shift toward patient-centric, patient-empowered healthcare and decision-making has highlighted...
Blog

Leveraging the Patent Priority Date: A Life Sciences Focus

The ACC last month hosted the San Francisco Bay Area Life Sciences CLE Conference, giving TransPerfect Legal Solutions (TLS) team members the opportunity to learn and connect with colleagues. One of the panels, moderated by Alex Trimble, Partner at Mintz Levin, Cohn, Ferris,...
Blog

Digital Health’s Role in Improving Patient Engagement

​In recent years, the patient journey has become more virtual, with patients seeking online information prior to engaging with healthcare providers (HCPs). Even as we transition back into traditional, in-person patient care, digital health is proving to be much more than just...
Blog

4 Ways a CCMS Can Help Medical Affairs Achieve Global Content Reuse and Omnichannel Delivery

The medical affairs industry is undergoing a widespread digital transformation in the new era of patient centricity. Pharma companies must adapt their delivery of important medical information, such as patient outcomes, to effectively reach relevant stakeholders if they want...
Blog

Leveraging Artificial Intelligence (AI) in Pharmacovigilance

Expert-driven technologies are continually being implemented into the clinical process to eliminate manual burdens and ramp up efficiencies. AI-enabled automated systems help to remove the barriers that prevent high-quality data and compliance in reporting of clinical events....
Blog

What’s Trending: Milestone Disputes in Life Sciences Litigation

Earlier this month, the ACC hosted an illuminating panel presentation on Life Sciences Litigation: A Look at Milestone Disputes & Recent Trends. Panelists included Lauri Mims and Jennifer Huber, both Partners at Keker Van Nest & Peters, and Ann Byers, Director, Shareholder...
Blog

The Evolving Machine Translation and Translation Memory Landscape for Life Sciences

Over the past 70+ years and to this day, translation technology has changed drastically as more companies are focusing on ways to improve their tech performance with data that is higher quality and customizable. Consequently, life sciences organizations have been...
Blog

Celebrating Women’s History Month with the Women of TransPerfect Life Sciences

March is Women’s History Month, and this year we wanted to take a moment to shine a spotlight on some of the hardworking women who make TransPerfect Life Sciences tick.Women have been historically underrepresented across STEM industries. In fact, according to the US...
Blog

A Comparison Between Document Management Systems (DMS) and Component Content Management Systems (CCMS) for Pharma

CHOOSING THE RIGHT OPTION FOR YOU AND YOUR BUSINESS NEEDSGlobal pharma companies produce and manage a lot of content that is complexly intertwined. To mitigate risk, ensure patient safety, meet regulatory compliance standards, and reduce cycle times for faster drug-to...
Blog

Your Treatment Plan for Curing the App Localization Headache

If translation had a prefrontal cortex, in-country review would create quite the headache. This is particularly true for app localization. App localization is the process of adapting apps and their content to another language in a conceptually equivalent and culturally...
Blog

TransPerfect Life Sciences Director Anne Rhea Selected as VP of HBA’s Paris Chapter

The life sciences industry has historically been a male-dominated field, with women being underrepresented or undervalued. In fact, according to BioSpace’s U.S. Life Sciences 2020 Diversity & Inclusion Report, there were large gaps between women and men in life...
Blog

Is Your Clinical Supply Strategy Ready for EU CTR?

The content in this blog is outdated. For the most recent information on EU CTR, see our latest blog here. OUTLINING IMP LABELLING CHANGES AND THEIR IMPLICATIONSIn May 2014, the European Union Clinical Trial Regulation (EU CTR) No. 536/2014 was passed,...
Blog

An Unlikely Perfect Pairing: Life Sciences & Translation

What Is Life Sciences Translation?Let’s first define the term “translation” within a life sciences context. Life sciences translation is the adaptation of clinical documentation and MedTech materials across different languages. While the concept may seem relatively simple, it...
Blog

The Importance of Over-the-Phone Interpretation for Emergency Services

Imagine calling 911 in a state of crisis at the scene of an emergency situation, only to hear the call handler trying to understand you. And there’s nothing wrong with the connection—the poor communication is only because the person doesn’t speak your language.This kind of...
Blog

Let’s Chat About Chatbots: Part 1

According to Valuates Reports, the conversational AI market is projected to reach $32.62 billion by 2030, up from $5.78 billion in 2020. While it is clear chatbots and their uses are growing, it’s important to understand what a chatbot is exactly, its uses and benefits,...
Blog

Let’s Chat About Chatbots: Part 2

In our last post, we discussed how business are deploying and benefiting from chatbots. Now that you have a basic understanding of what chatbots are and how they work, the next step is implementing them into your business model.For life sciences companies that are unsure...
Blog

What Do You Need to Know About Digital Marketing For Life Sciences in 2022?

There have been many consequences and unexpected changes for marketers since the start of the COVID-19 pandemic. One of them (especially in the life sciences arena) is the concept of forced innovation. As an industry, life sciences had traditionally been slow to embrace a...
Blog

Digital Health Tools and Patient Support in China

Digital health has been a trending topic in the life sciences space, and has gained particular momentum due to the COVID-19 outbreak. In 2020, the global digital health market was valued at over $141.8 billion. This is expected to increase in value at a compound...
Blog

Does a One-Stop-Shop Global Translation Provider Truly Exist?

Within the global translation market, there are over 200 global language service providers (LSPs), each reporting annual revenues larger than $1 million. Collectively, the 2020 revenue of all 200 companies equates to approximately $8 billion. All of these LSPs have...
Blog

5 Key Considerations for Implementing Digital Technologies to Support Patients in China

Patient support is a hot topic in the life sciences space. Healthcare providers are consistently looking for ways to improve patient care and better support patients’ needs. In our previous post, we discussed how China was paving the way in leveraging digital health...
Blog

5 Key Benefits of Linking Reporting to Your TMS

In the clinical world, monitoring and reviewing the status of translations across multiple countries has consistently been a challenge. Managing multilingual clinical trial documents such as patient recruitment materials and meeting country-specific regulatory...
Blog

C3 Summit Recap: Shaping the Future of eCOA/ePRO Highlights

The paper to digital migration of eCOAs/ePROs has been quite the journey, particularly in light of COVID-19. The rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local...
Blog

How Translation Can Increase Patient Engagement

As clinical research continues to expand across diverse markets and regions, it is imperative for data to reflect the global population. Data that is representative of all patients, including those of diverse backgrounds, ensures that the medical product in development serves...